In addition, the tumor-associated gene Activating Transcription Factor 3 (ATF3) was upregulated, and the oncogene Aldehyde Dehydrogenase 2 (ALDH2) was downregulated as the trajectory progressed (Supplementary Figure S4D). The gene discussed is ATF3; the disease is neoplasm.